导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.91% | 539/1050 |
| 近一周 | -3.46% | 975/1104 |
| 近一月 | -7.51% | 973/1103 |
| 近一季 | -12.99% | 812/1092 |
| 近半年 | -8.89% | 745/1070 |
| 近一年 | 4.77% | 490/1018 |
| 近两年 | 61.43% | 426/926 |
| 近三年 | 44.02% | 312/834 |
| 成立以来 | 84.92% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.60% 161/1070 |
14.77% 453/1101 |
- - |
- - |
| 2025 | 41.71% 300/1065 |
6.61% 309/1014 |
-1.97% 841/1038 |
43.46% 140/1050 |
-5.48% 718/1065 |
| 2024 | 12.45% 232/1011 |
1.19% 252/960 |
4.65% 110/983 |
11.82% 467/991 |
-5.03% 671/1011 |
| 2023 | -33.05% 828/952 |
-10.13% 849/880 |
-5.10% 528/895 |
-12.88% 718/915 |
-9.90% 851/952 |
| 2022 | -26.57% 543/867 |
-23.66% 691/773 |
12.75% 167/806 |
-10.17% 246/845 |
-5.03% 651/867 |
| 2021 | 25.53% 110/740 |
-9.73% 485/580 |
32.90% 40/659 |
-1.53% 244/704 |
6.26% 172/740 |
| 2020 | 52.31% 228/554 |
-5.12% 293/419 |
21.02% 268/466 |
22.49% 35/517 |
8.29% 385/554 |
| 2019 | 30.13% 287/410 |
19.35% 930/1149 |
1.88% 176/1231 |
2.00% 278/390 |
4.93% 340/410 |
| 2018 | - - |
- - |
- - |
- - |
-11.62% 499/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 汇添富智能制造股票A VS. 东吴新产业精选股票A(580008) |